Mary E. Valiga

1.4k citations
10 papers · 785 indexed · h-index 7

Mary E. Valiga

10 papers receiving 771 citations

Peers

Mary E. Valiga
Comparison fields: 5 of 54
  • Hepatology 451
  • Immunology 459
  • Virology 65
  • Epidemiology 344
  • Oncology 160
Replace D. Tola with:
D. Tola Italy
Nicole Castelblanco United States
Cristina Mori Italy
Luca Sacchelli Italy
Nadine Kersting Germany
Norbert H. Grüner Germany
Yuji Sobao Japan
Kerstin A. Stegmann United Kingdom
Martin Wächtler Germany
Michelle Brown United States
Mary E. Valiga relative to D. Tola Italy D. Tola's profile →
Citations per field
00.5×1.5×2.1×
D. Tola · 1×
Citations per year

Countries citing papers authored by Mary E. Valiga

Since Specialization
Citations

This map shows the geographic impact of Mary E. Valiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Valiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Valiga more than expected).

Fields of papers citing papers by Mary E. Valiga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Valiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Valiga. The network helps show where Mary E. Valiga may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mary E. Valiga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary E. Valiga Line = papers co-authored together Mary E. Valiga links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201414
2 201414
3 20121
4 2009303
5 200856
6 2008236
7
BASIC-LIVER, PANCREAS, AND BILIARY TRACT Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
20071
8 2006116
9 200542
10 20032

About Mary E. Valiga

Mary E. Valiga is a scholar working on Hepatology, Immunology, Virology, Epidemiology and Animal Science and Zoology, having authored 10 papers that have together received 785 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (4 papers), Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers), HIV Research and Treatment (1 paper), Systemic Lupus Erythematosus Research (1 paper), Diabetes and associated disorders (1 paper) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Hepatology (451 citations), Immunology (459 citations), Virology (65 citations), Epidemiology (344 citations) and Oncology (160 citations). Mary E. Valiga has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Kyong‐Mi Chang, Nobuhiro Nakamoto, Emma Gostick, Kim M. Olthoff, Mary Kaminski, Gordon J. Freeman, Abraham Shaked, David A. Price, E. John Wherry and David E. Kaplan. Their work appears in journals such as Gastroenterology, Hepatology, Journal of Clinical Gastroenterology, PLoS Pathogens and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026